Aim 3, Adapting & Implementing Evidence-based Breast Cancer Follow-up in

Status Not yet recruiting

Clinical Trial Summary

This mixed methods study evaluates the effectiveness of an organizational intervention to enhance implementation of strategies to increase breast cancer survivorship symptom and risk management.

Clinical Trial Description

Aim 3 is a hybrid type 1 effectiveness-implementation cluster randomized study with a waitlist control in 26 primary care practices. This study uses a tailored combination of practice facilitation, expert consultation, collaborative learning events, and audit and feedback as intervention strategies, and a mixed-methods comparative case study learning evaluation for primary care practices to adapt priority recommendations of evidence-based activities for breast cancer survivorship care. Intervention effectiveness will be assessed in two groups of clinics: 13 cases that will receive the implementation intervention and 13 waitlist controls. Impact of this implementation will be measured using mixed methods to assess Exploration, Preparation, Implementation and Sustainment factors related to how organizational and contextual variables affect adoption, implementation and early sustainability for provision of follow-up care, symptom, and risk management activities at 6 and 12 months post implementation. Aim 3 surveys 20 clinicians and staff members from 26 intervention practices (n=520) and conducts key informant interviews with 5 health care team members (who have participated in the survey; n=130) and 15 breast cancer survivors per practice (n=390; 5 per assessment point at baseline, 6 months and 12 months post intervention). Medical records of 20 patients with a history of breast cancer per practice per assessment point at baseline, 6 months and 12 months post intervention will be randomly selected for review (N=1,560) to assess and compare comprehensive breast cancer follow-up care outcomes. Sustainment will be measured through continued monitoring of the medical records for the 13 initial intervention practices at 18 and 24 months (N=520). ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05400941
Study type	Interventional
Source	Rutgers, The State University of New Jersey
Contact	Shawna V Hudson, PhD
Phone	848-932-0215
Email	hudsonsh@rwjms.rutgers.edu
Status	Not yet recruiting
Phase	N/A
Start date	June 2024
Completion date	December 2025

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05596474` - Effect of Beet-root Juice and PBM Treatments on Muscle Fatigue	N/A
Recruiting	`NCT05778578` - Universal Basic Income and Structural Racism in the US South	N/A
Not yet recruiting	`NCT05558332` - Youth Nominated Support Team	N/A
Completed	`NCT02451059` - Reducing Socioeconomic Disparities in Health at Pediatric Visits	N/A
Completed	`NCT05082935` - COVID-19: Healthy Oregon (Oregon Saludable): Together We Can (Juntos Podemos) Phase II	N/A
Recruiting	`NCT05454969` - One-4-ALL Initiative	N/A
Enrolling by invitation	`NCT05045222` - Economic and Clinical Outcomes of (Whole Exome) Sequencing in Tapestry
Completed	`NCT04587063` - Evaluation of Emails Promoting Mail-order Pharmacy	N/A
Recruiting	`NCT05541913` - The Effect of Tele-Nursing on Parents of Circumcised Children	N/A
Completed	`NCT05117333` - Reminders, Cost Sharing, and Healthcare Use	N/A
Recruiting	`NCT04835012` - Health and Health Care Utilization Effects of Medical Debt Forgiveness
Completed	`NCT04567342` - Effect of Varied Outreach Methods on Appointment Scheduling, Appointment Completion, and Receipt of MMR Vaccination	N/A
Withdrawn	`NCT05552638` - Telecare in Rural Senior Centers	N/A
Enrolling by invitation	`NCT04250103` - Home-based Longitudinal Investigation of the Multidisciplinary Team Integrated Care
Completed	`NCT04240093` - CoMBAT Opioid Use Disorder: A Combined Medication and Behavioral Activation Treatment for People Living With Opioid Use Disorder	N/A
Active, not recruiting	`NCT03724695` - Advanced Heart Care at Home	N/A
Completed	`NCT04517578` - European Neuromuscular Monitoring Survey
Active, not recruiting	`NCT05609188` - Black Economic Equity Movement	N/A
Active, not recruiting	`NCT04373135` - Understanding Community Considerations, Opinions, Values, Impacts, and Decisions for COVID-19	N/A
Recruiting	`NCT05324566` - Evaluation of ECG Transmission and AI Models Using Apple Watch ECGs and Symptoms Data Collected Using a Mayo iPhone App

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Aim 3, Adapting and Implementing Evidence-based Breast Cancer Follow-up in Primary Care

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms